Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 2,797-2,808 of 10,592
Drug study icon
CompletedNCT04693351

Troriluzole for OCD

This study is completed in the United States, in Canada, in the United Kingdom, .... It is testing troriluzole for OCD.

In United States
OCDDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Biohaven Pharmaceuticals, Inc.
Condition
OCD
Drug study icon
CompletedNCT01469039

ALKS 9072 (Also Known for schizophrenia

This study is completed in the United States, in Bulgaria, in Malaysia, .... It is testing ALKS 9072 (Also Known for schizophrenia.

In United States
SchizophreniaDrugFrom 18 Years to 70 Years
Countries
United States, Bulgaria, Malaysia, ...
Sponsor
Alkermes, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT01072929

Armodafinil Treatment for depression

This study is completed in the United States. It is testing armodafinil Treatment for depression.

In United States
Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Cephalon
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT02734693

Dasotraline for ADHD

This study is completed in the United States. It is testing dasotraline for ADHD.

Remote / online
ADHDDrugFrom 6 Years to 12 Years
Countries
United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
ADHD
Drug study icon
CompletedNCT03231800

Dasotraline for ADHD

This study is completed in the United States. It is testing dasotraline for ADHD.

In United States
ADHDDrugFrom 6 Years to 12 Years
Countries
United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
ADHD
Drug study icon
CompletedNCT07193563

ENX-102 for anxiety

This study is completed in the United States. It is testing ENX-102 for anxiety.

In United States
AnxietyDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Engrail Therapeutics INC
Condition
Anxiety
Drug study icon
CompletedNCT00309699

Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo for Bipolarity

This study is completed in the United States, in Greece, in Lithuania, .... It is testing Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo for Bipolarity.

Remote / online
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Greece, Lithuania, ...
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Bipolarity
Drug study icon
CompletedNCT03227224

JNJ-42847922 for depression

This study is completed in the United States, in France, in Bulgaria, .... It is testing JNJ-42847922 for depression.

In United States
DepressionDrugFrom 18 Years to 70 Years
Countries
United States, France, Bulgaria, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT06267846

NBI-1070770 for depression

This study is completed in the United States. It is testing NBI-1070770 for depression.

In United States
DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Neurocrine Biosciences
Condition
Depression
Drug study icon
CompletedNCT02969382

SEP-363856 for schizophrenia

This study is completed in the United States, in Hungary, in Romania, .... It is testing SEP-363856 for schizophrenia.

In United States
SchizophreniaDrugFrom 18 Years to 40 Years
Countries
United States, Hungary, Romania, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT01364662

SPN-810 for ADHD

This study is completed in the United States. It is testing SPN-810 for ADHD.

In United States
ADHDDrugFrom 6 Years to 12 Years
Countries
United States
Sponsor
Supernus Pharmaceuticals, Inc.
Condition
ADHD
Drug study icon
CompletedNCT00531752

Two Doses of PF-03654746 for ADHD

This study is completed in the United States. It is testing Two Doses of PF-03654746 for ADHD.

Remote / online
ADHDDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Pfizer
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.